National Institutes of Health awards contract for CRISPR-based disease modeling in iPS cell lines associated with Alzheimer’s, Stem cell pioneer Bill Skarnes joins advisory board
Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.
The Scientist Marketing Team | Sep 26, 2013 | 3 min read
The Scientist brings together a panel of experts who parse the hope and hype in an effort to educate the audience about the successes and caveats of using iPSCs.
Personalized stem cells improved motor symptoms and depression signs in monkeys modeling Parkinson’s disease, paving the way for trials in human patients.
The Scientist Marketing Team | May 23, 2016 | 1 min read
To explore the pros and cons of using iNPCs as a model for neuronal function and dysfunction, The Scientist is bringing together a panel of experts to share their experience with iNPCs and their forecast for iNPC disease modelling for human disease.